Revenue (Annual)

Revenue: The sum of all revenue fields included for a company's operating activities.

Integra LifeSciences Holdings Corporation (IART) had Revenue of $1.61B for the most recently reported fiscal year, ending 2024-12-31.

Quarterly Annual

Figures for fiscal year ending 2024-12-31

Income Statement Financials
Revenue	$1.61B
Net Income	$-6.94M
Cost of Goods Sold	$728.47M
Gross Profit	$882.06M
Operating Expenses	$1.58B
Operating Income	$28.41M
Non-Operating Income/Expense	$-46.65M
Pre-Tax Income	$-18.24M
Normalized Pre-Tax Income	$-18.24M
Income after Taxes	$-6.94M
Income from Continuous Operations	$-6.94M
Consolidated Net Income/Loss	$-6.94M
Normalized Income after Taxes	$-6.94M
EBIT	$28.41M
EBITDA	$174.90M
Weighted-Average Shares Outstanding (Basic)	77.01M
Weighted-Average Shares Outstanding (Diluted)	77.01M
Earnings per Share (EPS) (Basic)	$-0.09
Earnings per Share (EPS) (Diluted)	$-0.09
Balance Sheet Financials
Current Assets	$1.08B
Property, Plant, and Equipment	$405.72M
Long-Term Assets	$2.96B
Total Assets	$4.04B
Current Liabilities	$922.13M
Long-Term Debt	$1.20B
Long-Term Liabilities	$1.57B
Total Liabilities	$2.49B
Common Equity	$1.55B
Tangible Shareholders Equity	$-759.26M
Shareholders Equity	$1.55B
Common Shares Outstanding	81.72M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$129.38M
Cash Flow from Investing Activities	$-390.81M
Cash Flow from Financial Activities	$237.86M
Beginning Cash	$276.40M
End Cash	$246.38M
Increase/Decrease in Cash	$-30.03M
Stock-Based Compensation	$24.38M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.17
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.44
Debt to Equity Ratio	1.17
Gross Margin	54.77%
Operating Margin	1.76%
EBIT Margin	1.76%
EBITDA Margin	10.86%
Pre-Tax Profit Margin	-1.13%
Profit Margin	-0.43%
Free Cash Flow	$24.96M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.40
Inventory Turnover	1.70
Receiveable Turnover	5.91
Days Sales in Receivables	61.73
Return on Equity	-0.45%
Return on Tangible Equity	0.91%
Return on Assets	-0.17%
Return on Investments	-0.25%
Book Value Per Share	$18.91
Free Cash Flow per Share	$0.32
Operating Cash Flow per Share	$1.68

Data from Zacks Investment Research, Inc.